Across TCGA pan-cancer cohorts, FAM32BP RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of FAM32BP’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where FAM32BP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM32BP is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

KIRC, LUSC, and LIHC are the cancer types where FAM32BP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM32BP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+0.158	<.001	8	view →
LUSC	Male	All	−0.163	.001	4	view →
LIHC	Male	All	+0.118	<.001	4	view →
THCA	All	All	−0.124	<.001	3	view →
HNSC	Female	II,III,IV	+0.098	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: FAM32BP RNA expression & survival · all FAM32BP data types